Welcome to the Cannabis Investing Newsletter Forum. Feel free to find your favorite cannabis stocks and contribute content as you please; content that continues the discussion of and analysis of cannabis stocks. – D. H. Taylor

Clear all

Decibel Announces Third Results 2021

Trusted Member
Joined: 1 month ago
Posts: 58
Topic starter  

CALGARY, AB, Nov. 18, 2021 /CNW/ - Decibel Cannabis Company Inc. (the "Company" or "Decibel") (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce its third quarter financial results for the three month period ending September 30, 2021.

"Decibel's continued growth is a testament to our consumer focused approach, the strength of our brands, and our dedication towards producing high quality products for our customers", said Paul Wilson, CEO of Decibel. "We are closing out 2021 with strong momentum as we launch 40 new products, elevate the experience our products create for consumers, and innovate to meet cannabis consumers' evolving preferences."

Market Share

  • #9 largest LP by Canadian recreational market share, with 3.1% in September

Strong market share across BC, AB, SK, ON in September 20212,3:

  • #2 brand in premium flower sales with a 9.0% market share
  • #2 brand in concentrate sales with a 12.9% market share
  • #3 brand in vape sales with a 12.9% market share

Key Financial Highlights

  • Net Revenue: Net revenue was $13.4 million in Q3, a 7% increase over the prior quarter, driven by growth in Decibel's existing and newly launched flower, vape and concentrate products. Net revenue grew by 76% over the comparative 2020 quarter.
  • Flower Sales: 492 kilograms sold in Q3, with an average wholesale net price per gram of $7.65, an increase of 10% in kilograms sold and a decrease of 4% in average wholesale net price per gram, over the prior quarter. The decline in price per gram was a result of a greater volume allocation towards Qwest products versus Qwest Reserve products which achieves a higher price point and the launch of General Admission line of pre-rolls.
  • Derivative Sales: $6.6 million of net sales of vape and concentrate products in Q3, a 16% increase from the prior quarter. Sales growth was driven by increased demand for vape and concentrate products launched within Q3 and growth in Ontario demand as the province re-opened brick & mortar cannabis retail.
  • Retail Sales: $3.0 million of retail sales, a 5% decline over the prior quarter, primarily driven by new entrants into the Saskatchewan retail market, partially offset by Alberta retail sales growth.
  • Gross Profit: The Company achieved $4.1 million of gross profit before fair value adjustments, a decline of 20% from Q2 2021 and improvement of 42% over the prior year. Gross profit was impacted by a provision of $922 thousand, pertaining to the Plant inventory write offs. The inventory provision is primarily related to the write-off of unusable hardware, packaging materials, and various items related to discontinued products, as well as inventory held to satisfy an aged supply agreement that was mutually terminated.
  • Positive Adj. EBITDA: The Company achieved $1.8 million of adjusted EBITDA in Q3, its fifth consecutive quarter of positive adjusted EBITDA. This represented a decline of 17% from the prior quarter and improvement of 107% from the prior year. For the trailing twelve months, the Company has achieved $7.1 million in adjusted EBITDA.
  • Thunderchild Operational Development: The Company continues to invest in working capital as it ramps the facility and achieved run-rate harvests in mid-Q3. The Company anticipates run rate production by mid-Q4 at which point focus will be directed towards operational efficiency in post processing.
  • Product Innovation Roll-Out: In Q3 2021, Decibel introduced another six new product SKUs in addition to its rotational cultivar based products, ending with 57 products in market.
    • Generated approximately $182 thousand in net revenue per SKU in Q3, compared to $181 thousand in net revenue per product in the prior quarter.
    • Announced the launch of 40 new product SKUs between September 2021 and January 2022, including:
      • 12 new flower & pre-roll products that will replace existing cultivars in market.
      • 28 incremental new flower & derivative products.
  • Strengthened Balance Sheet: On September 16, 2021, the Company closed its bought deal prospectus offering with gross proceeds of $15 million The additional capital will accelerate Decibel's strategic plan through previously announced capital projects and a series of new product launches (See Decibel's Investor Presentation for further information). Net cash on the balance sheet as at September 30, 2021 was $11.3 million.

Quarterly Highlights


Three months ended
September 30

Nine months ended
September 30






Net wholesale revenue of flower 





Kilograms of flower sold






Average wholesale flower gross pricing per gram 





Average wholesale flower net pricing per gram





Kilograms of salable cannabis harvested






Net wholesale revenue of extracts






Number of retail stores






Retail revenue









Net revenue






Gross profit before fair value adjustments





Gross margin





Adjusted EBITDA1






Cash flow from operations 






Link to Decibel's Investor Presentation

Decibel's financial statements for the three-month period ending September 30, 2021 ("Financial Statements") and related Management's Discussion & Analysis ("MD&A") for the reporting period are available under the Company's profile at As of September 30, 2021, Decibel was in compliance with all of its financial covenants and expects to remain in compliance for the remainder of its twelve-month forecast period.  

1 Adjusted EBITDA is a non-GAAP performance measure. Refer to "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" for further details.

2 HiFyre Retail Analytics, Licensed Producer Sales over Time in BC, AB, SK, ON, September 1 – September 30, 2021

3 HiFyre Retail Analytics, Premium flower market defined as flower products sold more than 20% above average selling price per gram

Appointment of New Director

On November 17, 2021, Dr. Ivan Casselman was re-appointed to the Corporation's board of directors. Dr. Casselman brings a wealth of product and industry knowledge through his industry experience as an analytical chemist and plant medicine researcher, and his current roles as the Chief Psychedelic Officer at Havn. Dr. Casselman additionally holds a Master of Science in Ethnobotany and a Doctorate (Ph.d.) in Plant Science (analytical chemistry and genetics). Dr. Casselman was previously appointed to the board on November 24, 2020 but had been serving as a senior advisor since January 29, 2021 while awaiting his most recently granted Health Canada security clearance.

"Appointing Dr. Casselman to Decibel's board of directors is a great step in the evolution of the Corporation's governance and board composition" said Cody Church, the Chairman of Decibel's board of directors. "Dr. Casselman brings an extensive amount of experience and knowledge within the sector and adds a level of product and industry knowledge that will naturally compliment Decibel's current board of directors."

Active Member
Joined: 4 weeks ago
Posts: 13

I was just about to post that, thanks for getting it on the forum.   

Trusted Member
Joined: 1 month ago
Posts: 58
Topic starter  

@gtosali1967 Happy to help!!! If this a company you follow, please let me know your thoughts on the results!!!

D. H. Taylor
Member Admin
Joined: 1 year ago
Posts: 260

@b17jayhawker @gtosali1967 solid increase in revenue for these guys.  The numbers we have been seeing are organic growth at roughly 5%.  So, an increase of 7% in revenue growth beats the norm.  

JP liked